Total anti-SARS-CoV-2 antibodies measured 6 months after Pfizer-BioNTech COVID-19 vaccination in healthcare workers
2021; De Gruyter; Volume: 41; Issue: 2 Linguagem: Inglês
10.5937/jomb0-33999
ISSN1452-8258
AutoresGian Luca Salvagno, Brandon Michael Henry, Laura Pighi, Nitto de, Giuseppe Lippi,
Tópico(s)Inhalation and Respiratory Drug Delivery
ResumoThis study aimed at monitoring the kinetics of serum total anti-SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) antibodies in a cohort of healthcare workers after voluntary vaccination with Pfizer-BioNTech coronavirus disease 2019 (COVID-19) mRNA-based vaccine.
Referência(s)